PM Modi visits Bharat Biotech's vaccine manufacturing facility in Hyderabad

Covaxin, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, is now undergoing phase-3 trials. The Phase-3 trials involve 26,000 volunteers across India, conducted in partnership with ICMR.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39jGNVn
via IFTTT